United States securities and exchange commission logo
June 21, 2023
Andrew Freedman
Partner
Olshan Frome Wolosky LLP
1325 Avenue of the Americas
New York, New York 10019
Re: Diversified
Healthcare Trust
PRRN14A field June
15, 2023
Filed by Flat
Footed LLC and Marc Andersen
SEC File No.
001-15319
Dear Andrew Freedman:
We have reviewed your filing and have the following comments. In
some of our
comments, we may ask you to provide us with information so we may better
understand your
disclosure.
Please respond to these comments by providing the requested
information or advise us as
soon as possible when you will respond. If you do not believe our
comments apply to your facts
and circumstances, please tell us why in your response.
After reviewing your response to these comments, we may have
additional comments.
All defined terms have the same meaning as in your revised proxy
statement.
PRRN14A filed June 15, 2023
Reasons for the Solicitation, page 6
1. We note the reference
to an alternate acquisition proposal for DHC valued at $4.00 per
share in May 2022.
Since your disclosure unfavorably compares the current merger price
to that proposal,
expand to discuss the material contingencies to the May 2022 proposal.
For example, we
understand that it was conditioned on the contemporaneous acquisition
of another entity
managed by RMR and was further subject to due diligence.
2. We note the following
assertion on page 7 of the revised proxy statement relating to
RMR's fee arrangements:
"At the same time, RMR will continue to collect significant
fees as the external
manager for the post-Merger entity. Over the past four years alone,
RMR has collected over
$300 million in pure-profit management fees from OPI and DHC
combined despite
the woeful performance of both companies. Moreover, since a
substantial part of
these fees are calculated on enterprise value and construction costs
Andrew Freedman
Olshan Frome Wolosky LLP
June 21, 2023
Page 2
not profitability or equity value RMR appears perversely
incentivized to maximize
debt and spending: which we believe are the primary reasons why DHC
faces near-term
challenges today." Revise to balance this statement by describing how
RMR's fees are
partially tied to DHC's stock performance.
Additional Participant Information , page 18
3. We note the new disclosure on page 18 added in response to comment 2
in our last letter.
Revise here and in Flat Footed's Schedule 13D, as amended, to disclose
the specific
unsecured notes of DHC that Flat Foooted owns and the applicable
maturity dates for each
series.
4. See our last comment above and Item 5 of Schedule 14A. Expand the
disclosure to more
fully explain the participants' interests in the solicitation and the
merger, given their
ownership of DHC unsecured notes with an approximate aggregate
principal amount of
$154,821,275. Your expanded disclosure should address how their
interests are different
from those of equity shareholders of DHC, and should note the size of
your equity versus
debt interest in the company. To the extent that Flat Footed or other
participants in this
solicitation may seek to leverage their debt holdings to increase
their equity stake in DHC
in the future, this should be disclosed, as should any other potential
plans, such as
advocating for asset sales. Your expanded discussion should
specifically describe how the
interests of debt holders and equity holders may differ.
General
5. We understand that Flat Footed issued a press release on May 23, 2023
which was not
filed on EDGAR and did not include the Rule 14a-12 "legend" required
by Rule 14a-
12(a)(1). Please explain in your response letter why the May 23, 2023
press release was
not filed on EDGAR and why it did not include the Rule 14a-12 legend.
See Rule 14a-
6(o). To the extent that you believe Flat Footed was entitled to rely
on an exemption from
the proxy rules, please identify the exemption claimed and describe
the specific facts
which you believe support Flat Footed's reliance upon it.
We remind you that the filing persons are responsible for the accuracy
and adequacy of
their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Please direct any questions to Christina Chalk at (202) 551-3263.
FirstName LastNameAndrew Freedman Sincerely,
Comapany NameOlshan Frome Wolosky LLP
Division of
Corporation Finance
June 21, 2023 Page 2 Office of Mergers
& Acquisitions
FirstName LastName